News Articles Tagged: CCK Antagonist

The Science Behind Proglumide: Mechanisms of Action and Future Research Directions

Investigate the scientific underpinnings of Proglumide (CAS 6620-60-6), focusing on its CCK antagonism and its potential impact on neurological and pain-related conditions.

Proglumide: A Cholecystokinin Antagonist and its Multifaceted Pharmaceutical Applications

An in-depth look at Proglumide (CAS 6620-60-6), its function as a CCK antagonist, and its diverse applications in medicine and research.

Proglumide's Role in Pain Management: A Focus on Opioid Synergy and Tolerance Mitigation

Examine the dual action of Proglumide (CAS 6620-60-6) as an enhancer of opioid analgesia and a modulator of opioid tolerance, offering new perspectives for chronic pain treatment.

Exploring the Therapeutic Potential of Proglumide in Gastrointestinal Health

Delve into the historical and potential applications of Proglumide (CAS 6620-60-6) in managing gastrointestinal conditions, focusing on its CCK antagonism.

Proglumide: A Deep Dive into its Chemical Properties and Pharmaceutical Significance

Explore the detailed chemical structure, physical properties, and crucial pharmaceutical applications of Proglumide (CAS 6620-60-6), a significant cholecystokinin antagonist.

From Lab to Clinic: The Journey of Nastorazepide as a Pharmaceutical Intermediate by NINGBO INNO PHARMCHEM CO.,LTD.

NINGBO INNO PHARMCHEM CO.,LTD. discusses Nastorazepide's transition from a research compound to a pharmaceutical intermediate, emphasizing its role in developing new treatments for cancer and other conditions.

The Pharmaceutical Significance of Nastorazepide (Z-360): An API for Advanced Research by NINGBO INNO PHARMCHEM CO.,LTD.

NINGBO INNO PHARMCHEM CO.,LTD. highlights Nastorazepide (Z-360) as a critical Active Pharmaceutical Ingredient (API) for advanced research, focusing on its CCK-2 receptor antagonism and potential in cancer therapy development.

Exploring Nastorazepide: A Deep Dive into CCK-2 Receptor Antagonism and Its Applications by NINGBO INNO PHARMCHEM CO.,LTD.

NINGBO INNO PHARMCHEM CO.,LTD. provides an in-depth look at Nastorazepide (Z-360), focusing on its function as a CCK-2 receptor antagonist and its diverse applications in research, including potential in pain relief and metastasis inhibition.

The Role of Nastorazepide in Advanced Pancreatic Cancer Treatment: A Scientific Overview by NINGBO INNO PHARMCHEM CO.,LTD.

NINGBO INNO PHARMCHEM CO.,LTD. explores the scientific basis of Nastorazepide (Z-360) as a CCK-2 receptor antagonist and its emerging role in pancreatic cancer therapy, including combination strategies.